Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Localized bile acid improves systemic blood glucose control

Aug. 11, 2020

New hypothalamic obesity treatment target identified

Aug. 10, 2020

Topline data presented from phase III CARE-PWS study of LV-101

Aug. 7, 2020

TXNIP inhibition nixes T2D

Aug. 7, 2020

Dogma Therapeutics describes PCSK9 inhibitors

Aug. 5, 2020

Fish model identifies druggable osteoporosis targets

Aug. 3, 2020

New MGAT2 inhibitors discovered at Shionogi

July 30, 2020

Cascade (Shanghai) Pharmaceutical Technology patents AMPK activators

July 29, 2020

Vertex begins phase II trial of VX-864 in PiZZ genotype AAT deficiency

July 27, 2020

New phase I/II trial explores use of DNL-310 for pediatric patients with Hunter's syndrome

July 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...